جستجوی استاد راهنمای دانشگاهی

• Cardiovascular Disease
• Epidemiology
• Atrial Fibrillation
• +۵ مورد دیگر

Maxime Bos is a Researcher in the Department of Epidemiology at Erasmus Medical Center. His work primarily focuses on cardiovascular epidemiology, with particular emphasis on atrial fibrillation, Mendelian randomization, and genetic studies related to cardiovascular diseases. Dr. Bos's research interests span several key areas in cardiovascular epidemiology: Genetic determinants of cardiovascular diseases Atrial fibrillation and related conditions Mendelian randomization approaches Metabolomics in cardiovascular disease Large cohort studies including the Rotterdam Study and UK Biobank His recent publication record shows a strong focus on genome-wide association studies, cardiovascular disease mechanisms, and the intersection of metabolic disorders with cardiovascular outcomes. Dr. Bos frequently collaborates with researchers across multiple international cohorts and consortia, including the LifeLines Cohort Study and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Dr. Bos has contributed to significant research in cardiovascular epidemiology, with publications in high-impact journals including the American Journal of Cardiology, Journal of the American Heart Association, Diabetes Care, and Cell Reports. His work has been cited multiple times and has received attention in news outlets and social media, indicating its relevance to the broader scientific community and public health discourse.

Mark Haigneyمشاهده پروفایل

پزشک-پژوهشگر

• Sudden Death in the Young
• Drug Induced Arrhythmia
• Cardiac Arrhythmias
• +۳ مورد دیگر

Mark Haigney is an MD Cardiologist and Physician Scientist at the Uniformed Services University of the Health Sciences (USUHS), specializing in Military Cardiovascular Outcomes Research (MiCOR) Cardiology. He serves as Editor-in-Chief of the Annals of Noninvasive Electrocardiology since 2022 and has established himself as a leading expert in cardiac arrhythmias, particularly in military and veteran populations. Dr. Haigney completed his Cardiology Fellowship at Johns Hopkins Hospital (1990-1994) and received his medical education from Vanderbilt University Medical Center. His extensive research career spans over three decades with more than 180 research outputs, significant media coverage, and over 7,500 citations reflecting his substantial impact in the field. His primary research interests focus on Sudden Death in the Young and Drug Induced Arrhythmia, with particular emphasis on cardiac arrhythmias, heart failure, opioid-related cardiovascular complications, and military-specific cardiovascular health issues. His work frequently appears in high-impact journals including the Journal of the American College of Cardiology. Dr. Haigney leads multiple significant research projects including ERASE (Electrocardiogram Risk Assessment to Prevent Sudden Cardiac Events), SPIRIT (Sleep, hypertension, and cardiovascular disease in Injured veterans program), COVIVA (Ivabradine in Long Haul Covid), GEMINI (Genetic Contributions to Cardiac Arrest in the Military), and SCATES (Sudden Cardiac Arrest Tool for Electrocardiographic Screening in Military), demonstrating his commitment to addressing critical cardiovascular issues in military populations. Carol Johns Medal for Service (2013) His editorial leadership as Editor-in-Chief of Annals of Noninvasive Electrocardiology since 2022 and extensive media coverage of his research (19 press/media mentions including features in news outlets, blogs, podcasts, and Wikipedia) highlight his prominence in the field. His research has been widely disseminated with significant social media engagement and academic readership across platforms. Dr. Haigney works extensively with collaborators including Lydia Hellwig, Ian Stewart, and Andrew Franzos across multiple institutions, focusing on translational research that bridges military medicine, cardiology, and public health to improve cardiovascular outcomes for service members and veterans.

• Cardiovascular Diseases
• Neurology
• Electronic Nicotine Delivery Systems
• +۳ مورد دیگر

Roya S. Moheimani, MD is a Clinical Assistant Professor at the Charles R. Drew University of Medicine and Science in the Department of Physical Medicine and Rehabilitation . Her research spans cardiovascular physiology, neurology, and pain management, with a focus on the effects of electronic and tobacco cigarettes on autonomic nervous system function and oxidative stress biomarkers. Research Interests: Cardiovascular Diseases Electronic Nicotine Delivery Systems Sympathetic Nervous System Pain Management Neurology Publication Trends: Moheimani’s work (2014–2024) examines electronic cigarette impacts on cardiovascular health (e.g., endothelial function, cardiac sympathetic activity), neurology (e.g., complex regional pain syndrome, neurosyphilis imaging), and interventional pain management (e.g., nerve stimulation, disinfectant protocols). Her research often involves human studies and cross-disciplinary analysis. Labs & Collaborations: She collaborates with researchers like Middlekauff HR and co-authors in cardiology, neurology, and pain medicine, though specific lab affiliations are not detailed in the provided texts.

• Cardiovascular Diseases
• Metabolic Disorders
• Heart Failure with Preserved Ejection Fraction
• +۳ مورد دیگر

Dan (Amanda) Tong, M.D., Ph.D., serves as an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and is an active member of the Division of Cardiology. As a physician-scientist, she bridges clinical cardiology practice with molecular research, focusing on cardiovascular conditions linked to metabolic disorders. Her educational journey includes: Medical Degree: Tongji Medical College, China Ph.D.: University of Western Ontario, Canada Research Fellowship: Harvard Medical School Internal Medicine Residency: University of Iowa Cardiology Fellowship: UT Southwestern Medical Center Dr. Tong's research centers on the molecular mechanisms of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF), particularly in the context of systemic metabolic disorders like diabetes and obesity. She investigates pathways involving AMP-activated protein kinase, nitrosative stress, lipid metabolism, and sex differences, aiming to translate discoveries into novel therapies. Her work emphasizes the metabolic underpinnings of cardiac dysfunction, with implications for precision medicine approaches. Analysis of Dr. Tong's publication record reveals a cohesive trajectory exploring metabolic-cardiovascular intersections, primarily in high-impact journals like Circulation and Nature . Her research demonstrates consistent focus on HFpEF pathophysiology, therapeutic interventions (e.g., NAD+ repletion), and sex-specific protective mechanisms, establishing her as an emerging leader in metabolic cardiology. Dr. Tong holds certification from the American Board of Internal Medicine in Cardiovascular Medicine and actively participates in professional societies including the American Heart Association and American College of Cardiology. Leading the Tong Lab at the Harry S. Moss Heart Center, she directs a research program investigating cardiovascular diseases associated with metabolic disorders. The lab employs molecular, cellular, and preclinical approaches to unravel disease mechanisms and identify therapeutic targets, with particular emphasis on translating basic science discoveries into clinical solutions for HFpEF and AF.

• Mitochondrial biology
• calcium signaling
• ion channels
• +۹ مورد دیگر

Vivek Garg serves as Assistant Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine, where he leads research on mitochondrial calcium signaling mechanisms and their physiological implications. His work bridges molecular biophysics with cardiovascular pathophysiology, utilizing innovative electrophysiological approaches to investigate fundamental cellular processes. Education: B.Pharmacy in Pharmacology, Panjab University, India (1999) M.Pharmacy in Pharmacology, Panjab University, India (2002) Ph.D. in Pharmacology, The Ohio State University (2009) Postdoctoral Fellowship, University of Utah (2014) Researcher Position, University of California San Francisco (2020) Dr. Garg's research centers on mitochondrial bioenergetics and membrane excitability, with particular emphasis on the molecular physiology of mitochondrial calcium uniporter (MCU) complexes. His laboratory employs direct patch-clamp techniques on intracellular organelles combined with cell biology and multi-omics approaches to decipher how mitochondrial calcium signaling regulates cellular metabolism and electrical activity. This work has significant implications for understanding heart failure, metabolic disorders, and other conditions involving mitochondrial dysfunction. Analysis of his publication record reveals a consistent trajectory from cardiac ion channel research toward specialized mitochondrial electrophysiology. His recent work demonstrates technical innovation in organelle patch-clamp methodology while establishing critical regulatory mechanisms for MCU through EF-hand domain proteins. The publications span fundamental biophysical characterization to disease-relevant models, particularly focusing on cardiac pathophysiology and metabolic plasticity. Scientific Awards: No scientific awards documented in provided materials Dr. Garg currently serves as Principal Investigator on a National Institute of General Medical Sciences R01 grant (2023-2027) titled 'Molecular Physiology of Mitochondrial Calcium Uniporter (MCU)', reflecting the significance of his research program. While no formal advisees are listed in the provided documentation, he directs the Garg Lab which maintains active research operations focused on mitochondrial function. The Garg Lab operates within the Department of Pharmacology & Physiology, utilizing specialized equipment for mitochondrial patch-clamp recordings, confocal imaging, and omics analyses. Their research program investigates how mitochondrial abnormalities contribute to disease states through altered bioenergetics and signaling pathways, with particular attention to calcium and redox homeostasis in cardiac and metabolic contexts.

Süha Çetinمشاهده پروفایل

دانشیار

• Cardiology
• Interventional Cardiology
• Echocardiography
• +۴ مورد دیگر

Prof. Dr. Süha Çetin is an Associate Professor and interventional cardiologist at Okan University Hospital in Istanbul, where he has served in the Department of Cardiology since 2016. Fluent in German and English, he specializes in advanced cardiac imaging and interventional procedures, with clinical expertise developed through training at Ulm University and institutions in North America and the UK. Education Medical Education: University of Tübingen, Germany Cardiology Specialist Training: University of Ulm, Germany Cardiology Education: Ohio, North America Interventional Cardiology Training: Bristol Heart Institute and Leicester Royal Infirmary, UK Research Interests His research centers on cardiovascular pathophysiology in sleep disorders, particularly obstructive sleep apnea's impact on cardiac structure and function. He employs advanced echocardiographic techniques including speckle tracking to investigate left atrial/ventricular remodeling, coronary microvascular dysfunction in diabetes, and cardiotoxicity in cancer survivors. His work bridges clinical cardiology with metabolic and autoimmune conditions. Publication Trends Analysis of his 15 most recent publications (2014-2024) reveals persistent focus on sleep apnea-cardiac interactions (37% of works), with secondary themes in diabetic coronary disease (13%), cardio-oncology (7%), and stroke-related cardiac mechanisms (13%). Over 60% utilize echocardiography innovations, demonstrating his methodological specialization in strain imaging and functional assessment. Recurring co-authors indicate established collaborations with Vural MG and Heper G across multiple studies.

Ziva Cooperمشاهده پروفایل

دانشیار

• Cannabis Use Disorder
• Neuropharmacology
• Chronic Pain Management
• +۶ مورد دیگر

Dr. Ziva Cooper is the Research Director of the UCLA Cannabis Research Initiative and an Associate Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles. Her work focuses on cannabis pharmacology, substance use disorders, and harm reduction strategies, with particular expertise in neurocognitive effects and sex differences in cannabis use. Research Director, UCLA Cannabis Research Initiative Associate Professor, Psychiatry and Biobehavioral Sciences Member, Brain Research Institute Her research spans cannabis withdrawal mechanisms, medical applications for chronic pain, and public health implications of cannabis policy changes. Recent publications examine: Age-related cannabis effects Cardiovascular impacts of combusted cannabis Mobile EEG biomarkers Cannabinoid hyperemesis syndrome Interactions between cannabis and other substances Neuropsychopharmacology of pain and addiction Dr. Cooper actively investigates cannabis' role in the opioid crisis and contributes to policy discussions through collaborations with the National Academy of Sciences and community-based studies.